Filtered By:
Specialty: Cardiology
Condition: Cardiomyopathy
Procedure: PET Scan

This page shows you your search results in order of date.

Order by Relevance | Date

Total 7 results found since Jan 2013.

Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
CONCLUSIONS: An individual approach and targeted diagnostics using advanced medical technologies in selected patients, who may benefit from a tailored treatment regimen, can help reveal a probable cause in the majority of strokes and TIAs previously classified as cryptogenic.PMID:35146751 | DOI:10.1111/ane.13590
Source: Atherosclerosis - February 11, 2022 Category: Cardiology Authors: Barbara Ratajczak-Tretel Anna Tancin Lambert Dan Atar Anne Hege Aamodt Source Type: research

Outcome of patients receiving a continuous flow left ventricular assist device - a retrospective single center study.
Conclusions. Survival rates were good, although one third of patients were bridged with temporary circulatory support. We report a high level of freedom from pump thrombosis, fatal stroke, and driveline infection. PMID: 32292078 [PubMed - as supplied by publisher]
Source: Scandinavian Cardiovascular Journal - April 16, 2020 Category: Cardiology Tags: Scand Cardiovasc J Source Type: research

Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial
Conclusion In subjects with TRH, intensive lipid lowering with atorvastatin 80 mg is associated with a significant reduction in cardiovascular events.
Source: European Heart Journal - July 15, 2014 Category: Cardiology Authors: Bangalore, S., Fayyad, R., Laskey, R., DeMicco, D., Deedwania, P., Kostis, J. B., Messerli, F. H., Treating to New Targets Steering Committee and Investigators Tags: Heart failure/cardiomyopathy Source Type: research

Positron Emission Tomography-Computed Tomography for Imaging of Inflammatory Cardiovascular Diseases.
Abstract Inflammation is a determinant of atherosclerotic plaque rupture, the event usually responsible for myocardial infarction and stroke. Possible causes of inflammatory cardiomyopathy include myocarditis, eosinophilic disease, and sarcoidosis. Although conventional imaging techniques can identify the site and severity of luminal stenosis, they do not provide information regarding inflammatory status. (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for imaging of inflammatory cardiovascular diseases has been rapidly evolving. Integrated PET/computed tomography (CT) is becoming the method of c...
Source: Circulation Journal - May 9, 2014 Category: Cardiology Authors: Miyagawa M, Yokoyama R, Nishiyama Y, Ogimoto A, Higaki J, Mochizuki T Tags: Circ J Source Type: research

Relation of Interatrial Block to New-Onset Atrial Fibrillation in Patients With Chagas Cardiomyopathy and Implantable Cardioverter-Defibrillators
Chagas cardiomyopathy is an endemic disease in Latin America. A significant proportion of patients develop atrial fibrillation (AF), which may result in stroke and increased morbidity or mortality. Interatrial block (IAB) has been associated with the development of AF in different clinical scenarios. The aim of our study was to determine whether IAB can predict new-onset AF in patients with Chagas cardiomyopathy and implantable cardioverter-defibrillators (ICDs). We conducted a retrospective study of patients with Chagas cardiomyopathy and ICDs from 14 centers in Latin America. Demographics, clinical, and device follow-up ...
Source: The American Journal of Cardiology - March 3, 2014 Category: Cardiology Authors: Andres Enriquez, Diego Conde, Francisco Femenia, Antoni Bayés de Luna, Antonio Ribeiro, Claudio Muratore, Mariana Valentino, Enrique Retyk, Nestor Galizio, Wilma M. Hopman, Adrian Baranchuk Tags: Cardiomyopathy Source Type: research

Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
CONCLUSIONS: Catheter ablation of AF in patients with HCM is an effective and safe therapeutic option, particularly in patients with paroxysmal AF. Effectiveness of ablation is significantly smaller in patients with persistent AF and even more so in those with long-persistent AF. Repeated procedures were often necessary. Continued antiarrhythmic drug therapy is often required due to a significant degree of atrial remodelling. PMID: 23348529 [PubMed - in process]
Source: Polish Heart Journal - January 26, 2013 Category: Cardiology Authors: Derejko P, Polańska M, Chojnowska L, Michałowska I, Wójcik A, Piotrowicz E, Lech A, Kłopotowski M, Baranowski R, Przybylski A, Bilińska M, Sierpiński R, Walczak F, Szumowski L Tags: Kardiol Pol Source Type: research